Zaid Admani

That's a massive pool of money that these Wall Street firms want access to.

Like personally, that seems very risky to invest in a private equity or a private credit fund using your retirement money.

But I don't know, let me know what you guys think in the comments.

Do you think that these private credit funds should be allowed in 401ks?

If you look at the stock price of these private credit companies like Blue Owl and Blackstone and Apollo, the stock is down like 30 to 40% this year.

So yeah, we're gonna continue to keep an eye on the private credit space.

Cause like I said, a lot of smoke there right now.

In return, Eli Lilly will get access to Insilico's AI model called pharma.ai, and they'll get exclusive worldwide rights to develop and commercialize potential medicines.

This is a pretty big deal because Insilico has already developed at least 28 drugs using generative AI tools, and nearly half of those drugs are already in clinical stages.

And it speaks to how advanced China is becoming when it comes to drug development, a lot of it due to AI.

Insilico is headquartered in Cambridge, Massachusetts, but conducts its R&D in China, and it's backed by the Hong Kong government's investment arm.

In fact, the company went public in Hong Kong back in December, and the stock is already up 50% this year.

And Eli Lilly and Silico have already been working together since 2023.

So this deal expands a relationship that already existed.

So yeah, drug development in China is moving fast.

So the Chinese pharma companies might be a space to watch over the next couple of years.

Let's talk about some stocks making moves today.

Shares of the aluminum producer Alcoa are rising this morning after two major aluminum producers in the Middle East were attacked by Iran over the weekend.

The Middle East accounts for about 9% of global aluminum production, according to the bank ANZ, and the firm recently warned that four to five million metric tons of aluminum exports are at risk,

because of the war.